Poly(ADP-ribose) polymerase-1 (PARP-1) regulates developmental morphogenesis and chemotaxis in Dictyostelium discoideum

被引:7
|
作者
Jubin, Tina [1 ]
Kadam, Ashlesha [1 ]
Begum, Rasheedunnisa [1 ]
机构
[1] Maharaja Svajirao Univ Baroda, Fac Sci, Dept Biochem, Vadodara 390002, India
关键词
cAMP signalling; cell differentiation; development; ADP-RIBOSE POLYMERASE-1; CELL-DEATH; OXIDATIVE STRESS; GENE-EXPRESSION; SLIME-MOLD; GROWTH; PHOSPHODIESTERASE; INVOLVEMENT; AGGREGATION; PROTEIN;
D O I
10.1111/boc.201800056
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background information Poly(ADP-ribose) polymerase-1 (PARP-1) has been attributed to varied roles in DNA repair, cell cycle, cell death, etc. Our previous reports demonstrate the role of PARP-1 during Dictyostelium discoideum development by its constitutive downregulation as well as by PARP-1 ortholog, ADP ribosyl transferase 1 A (ADPRT1A) overexpression. The current study analyses and strengthens the function of ADPRT1A in multicellular morphogenesis of D. discoideum. ADPRT1A was knocked out, and its effect was studied on cAMP signalling, chemotaxis and development of D. discoideum. Results We report that ADPRT1A is essential in multicellular development of D. discoideum, particularly at the aggregation stage. Genetic alterations of ADPRT1A and chemical inhibition of its activity affects the intracellular and extracellular cAMP levels during aggregation along with chemotaxis. Exogenous cAMP pulses could rescue this defect in the ADPRT1A knockout (ADPRT1A KO). Expression analysis of genes involved in cAMP signalling reveals altered transcript levels of four essential genes (PDSA, REGA, ACAA and CARA). Moreover, ADPRT1A KO affects prespore- and prestalk-specific gene expression and prestalk tendency is favoured in the ADPRT1A KO. Conclusion ADPRT1A plays a definite role in regulating developmental morphogenesis via cAMP signalling. Significance This study helps in understanding the role of PARP-1 in multicellular development and differentiation in higher complex organisms.
引用
收藏
页码:187 / 197
页数:11
相关论文
共 50 条
  • [21] Evolution of Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors. From Concept to Clinic
    Ferraris, Dana V.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (12) : 4561 - 4584
  • [22] Poly(ADP-ribose)polymerase-1 (PARP-1) expression and activity in primary human lung cells
    Ahmad, MH
    Torky, A
    Glahn, F
    Raemisch, A
    Foth, H
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 113 - 113
  • [23] Synthesis and Evaluation of a Radioiodinated Tracer with Specificity for Poly(ADP-ribose) Polymerase-1 (PARP-1) in Vivo
    Zmuda, Filip
    Malviya, Gaurav
    Blair, Adele
    Boyd, Marie
    Chalmers, Anthony J.
    Sutherland, Andrew
    Pimlott, Sally L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (21) : 8683 - 8693
  • [24] Poly (ADP-ribose) polymerase-1 (PARP-1) in Chinese patients with Graves' disease and Graves' ophthalmopathy
    Wu, Tong
    Tang, Dong-run
    Zhao, Liang
    Sun, Feng-yuan
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2018, 96 (06) : 556 - 561
  • [25] The role of poly(ADP-ribose) polymerase-1 (PARP-1) in the cellular response to Topoisomerase I poisons
    Smith, L
    Willmore, E
    Hostomsky, Z
    Webber, SE
    Austin, CA
    Curtin, NJ
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S69 - S69
  • [26] Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)
    Miyashiro, Julie
    Woods, Keith W.
    Park, Chang H.
    Liu, Xuesong
    Shi, Yan
    Johnson, Eric F.
    Bouska, Jennifer J.
    Olson, Amanda M.
    Luo, Yan
    Fry, Elizabeth H.
    Giranda, Vincent L.
    Penning, Thomas D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (15) : 4050 - 4054
  • [27] Inhibition of poly (ADP-ribose) Polymerase-1 (PARP-1) improves endothelial function in pulmonary hypertension
    Shafiq, Mohammad
    Lone, Zahid Rasool
    Abdulkareem, Adam Olaitan
    Kaur, Gurpreet
    Navya, Sai
    Singh, Himalaya
    Jagavelu, Kumaravelu
    Hanif, Kashif
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 80
  • [28] Poly(ADP-ribose) polymerase-1 (PARP-1) gene deficiency alleviates diabetic kidney disease
    Shevalye, H.
    Maksimchyk, Y.
    Watcho, P.
    Obrosova, I. G.
    DIABETOLOGIA, 2010, 53 : S50 - S50
  • [29] Studies on Benzofuran-7-carboxamides as Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors
    Lee, Sunkyung
    Yi, Kyu Yang
    Lee, Byung Ho
    Oh, Kwang Seok
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2012, 33 (04) : 1147 - 1153
  • [30] Poly(ADP-ribose) polymerase-1 (PARP-1) gene deficiency alleviates diabetic kidney disease
    Shevalye, Hanna
    Maksimchyk, Yury
    Watcho, Pierre
    Obrosova, Irina G.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2010, 1802 (11): : 1020 - 1027